rotenone has been researched along with Cranial Nerve II Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gonzalez-Lima, F; John, JM; Lee, J; Rojas, JC | 2 |
| Gonzalez-Lima, F; Jones, D; Zhang, X | 1 |
3 other study(ies) available for rotenone and Cranial Nerve II Diseases
| Article | Year |
|---|---|
Neuroprotective effects of near-infrared light in an in vivo model of mitochondrial optic neuropathy.
Topics: Animals; Brain; Electron Transport Complex I; Electron Transport Complex IV; Immunohistochemistry; Infrared Rays; Male; Mitochondria; Optic Nerve Diseases; Rats; Rats, Long-Evans; Rotenone; Superoxide Dismutase; Uncoupling Agents | 2008 |
Methylene blue provides behavioral and metabolic neuroprotection against optic neuropathy.
Topics: Adaptation, Ocular; Analysis of Variance; Animals; Brain; Choice Behavior; Discrimination, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Electron Transport Complex I; Insecticides; Male; Methylene Blue; Mitochondria; NADH Dehydrogenase; Neurons; Neuroprotective Agents; Optic Nerve Diseases; Photic Stimulation; Rats; Rats, Long-Evans; Reaction Time; Retina; Rotenone; Visual Pathways | 2009 |
Mouse model of optic neuropathy caused by mitochondrial complex I dysfunction.
Topics: Animals; Dimethyl Sulfoxide; Disease Models, Animal; Male; Mice; Mice, Inbred CBA; Mitochondria; Mitochondrial Diseases; Optic Nerve Diseases; Pharmaceutical Vehicles; Quinone Reductases; Retinal Ganglion Cells; Rotenone; Time Factors; Uncoupling Agents | 2002 |